Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Graffner

Showing results (61-70 of 62) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 62 results.
Alimentary Pharmacology & Therapeutics|January 16, 2009
Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitisC Pena-Rossi, S Schreiber, G Golubovic, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's diseaseR W Stockbrügger, E J Schoon, S Bollani, et al.
Pageof 7

Showing results (61-70 of 62) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 62 results.
Alimentary Pharmacology & Therapeutics|January 16, 2009
Clinical trial: a multicentre, randomized, double-blind, placebo-controlled, dose-finding, phase II study of subcutaneous interferon-beta-la in moderately active ulcerative colitisC Pena-Rossi, S Schreiber, G Golubovic, et al.
Alimentary Pharmacology & Therapeutics|August 17, 2002
Discordance between the degree of osteopenia and the prevalence of spontaneous vertebral fractures in Crohn's diseaseR W Stockbrügger, E J Schoon, S Bollani, et al.
Pageof 7